Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

<p>Immunotherapy for Medulloblastoma: Current Perspectives</p>
Tanvir Kabir, Charles A. Kunos, John L. Villano, et al.
ImmunoTargets and Therapy (2020) Vol. Volume 9, pp. 57-77
Open Access | Times Cited: 38

Showing 1-25 of 38 citing articles:

Medulloblastoma: Current Perspectives and Recent Advances
Jung Yoon Choi
Brain Tumor Research and Treatment (2023) Vol. 11, Iss. 1, pp. 28-28
Open Access | Times Cited: 25
Advances in NK cell therapy for brain tumors
Jawad Fares, Zachary Davis, Julian S. Rechberger, et al.
npj Precision Oncology (2023) Vol. 7, Iss. 1
Open Access | Times Cited: 24
The SHH/GLI signaling pathway: a therapeutic target for medulloblastoma
Ludovica Lospinoso Severini, Francesca Ghirga, Francesca Bufalieri, et al.
Expert Opinion on Therapeutic Targets (2020) Vol. 24, Iss. 11, pp. 1159-1181
Open Access | Times Cited: 51
Medulloblastoma in the Modern Era: Review of Contemporary Trials, Molecular Advances, and Updates in Management
Margot Lazow, Joshua D. Palmer, Maryam Fouladi, et al.
Neurotherapeutics (2022) Vol. 19, Iss. 6, pp. 1733-1751
Open Access | Times Cited: 24
Hedgehog Pathway Inhibitors against Tumor Microenvironment
Silpa Gampala, Jer‐Yen Yang
Cells (2021) Vol. 10, Iss. 11, pp. 3135-3135
Open Access | Times Cited: 30
Cancer Predisposition Syndromes and Medulloblastoma in the Molecular Era
Roberto Carta, Giada Del Baldo, Evelina Miele, et al.
Frontiers in Oncology (2020) Vol. 10
Open Access | Times Cited: 28
Terahertz spectrum-based refractive index sensor for brain lesion detection using photonic crystal fibers
M. Naim, Jabin Tasnin Upoma, A. H. M. Iftekharul Ferdous, et al.
PLoS ONE (2025) Vol. 20, Iss. 3, pp. e0320355-e0320355
Open Access
High B7-H3 protein expression in Medulloblastoma is associated with metastasis and unfavorable patient outcomes
Patrícia Fontão, Gustavo Ramos Teixeira, Daniel Antunes Moreno, et al.
Diagnostic Pathology (2025) Vol. 20, Iss. 1
Open Access
Heterozygous Kmt2d loss diminishes enhancers to render medulloblastoma cells vulnerable to combinatory inhibition of LSD1 and OXPHOS
Shilpa S. Dhar, Calena Brown, Ali A. Rizvi, et al.
Cell Reports (2025) Vol. 44, Iss. 5, pp. 115619-115619
Closed Access
Relapsed Medulloblastoma in Pre-Irradiated Patients: Current Practice for Diagnostics and Treatment
Rebecca M. Hill, Sabine Plasschaert, Beate Timmermann, et al.
Cancers (2021) Vol. 14, Iss. 1, pp. 126-126
Open Access | Times Cited: 21
Pediatric Central Nervous System Tumor Overview and Emerging Treatment Considerations
Sudarshawn Damodharan, Diane Puccetti
Brain Sciences (2023) Vol. 13, Iss. 7, pp. 1106-1106
Open Access | Times Cited: 9
Advances in CAR-T therapy for central nervous system tumors
Delian Zhou, Xiaojian Zhu, Yi Xiao
Biomarker Research (2024) Vol. 12, Iss. 1
Open Access | Times Cited: 3
New Approaches in Targeted Therapy for Medulloblastoma in Children
H. Maier, Tina Dalianis, Ourania N. Kostopoulou
Anticancer Research (2021) Vol. 41, Iss. 4, pp. 1715-1726
Open Access | Times Cited: 20
Immunotherapy in Medulloblastoma: Current State of Research, Challenges, and Future Perspectives
Marije J. Voskamp, Shuang Li, Kim Robin van Daalen, et al.
Cancers (2021) Vol. 13, Iss. 21, pp. 5387-5387
Open Access | Times Cited: 19
Childhood Medulloblastoma: An Overview
Yujin Suk, William D. Gwynne, Ian Burns, et al.
Methods in molecular biology (2022), pp. 1-12
Closed Access | Times Cited: 13
Digital expression profile of immune checkpoint genes in medulloblastomas identifies CD24 and CD276 as putative immunotherapy targets
Rui Ferreira Marques, Daniel Antunes Moreno, Luciane da Silva, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
Exploring the Molecular Complexity of Medulloblastoma: Implications for Diagnosis and Treatment
Julian S. Rechberger, Stephanie Toll, Wouter J. F. Vanbilloen, et al.
Diagnostics (2023) Vol. 13, Iss. 14, pp. 2398-2398
Open Access | Times Cited: 8
Targeting the gp130/STAT3 Axis Attenuates Tumor Microenvironment Mediated Chemoresistance in Group 3 Medulloblastoma Cells
Lakshana Sreenivasan, Ling Vicky Li, Pascal Leclair, et al.
Cells (2022) Vol. 11, Iss. 3, pp. 381-381
Open Access | Times Cited: 10
The Current Landscape of Targeted Clinical Trials in Non-WNT/Non-SHH Medulloblastoma
David R. Ghasemi, Gudrun Fleischhack, Till Milde, et al.
Cancers (2022) Vol. 14, Iss. 3, pp. 679-679
Open Access | Times Cited: 8
Immunotherapy for Neuro-oncology
Nazanin Majd, Pushan Dasgupta, John de Groot
Advances in experimental medicine and biology (2021), pp. 233-258
Closed Access | Times Cited: 8
Musashi-1 regulates cell cycle and confers resistance to cisplatin treatment in Group 3/4 medulloblastomas cells
Pablo Shimaoka Chagas, Luciana Chain Veronez, Graziella Ribeiro de Sousa, et al.
Human Cell (2023) Vol. 36, Iss. 6, pp. 2129-2139
Open Access | Times Cited: 3
Medulloblastoma targeted therapy: From signaling pathways heterogeneity and current treatment dilemma to the recent advances in development of therapeutic strategies
Qiyue Wang, Xiaofei Xin, Qihao Dai, et al.
Pharmacology & Therapeutics (2023) Vol. 250, pp. 108527-108527
Closed Access | Times Cited: 3
Immunotherapy for Pediatric Brain and Spine Tumors: Current State and Future Directions
Dagoberto Estévez-Ordoñez, Sam E. Gary, Travis J. Atchley, et al.
Pediatric Neurosurgery (2022) Vol. 58, Iss. 5, pp. 313-336
Open Access | Times Cited: 5
Effect of Autograft CD34+ Dose on Outcome in Pediatric Patients Undergoing Autologous Hematopoietic Stem Cell Transplant for Central Nervous System Tumors
Tristan Knight, Kwang Woo Ahn, Kyle Hebert, et al.
Transplantation and Cellular Therapy (2023) Vol. 29, Iss. 6, pp. 380.e1-380.e9
Open Access | Times Cited: 2
Identification of an Immunogenic Medulloblastoma-Specific Fusion Involving EPC2 and GULP1
Claudia Paret, Nadine Lehmann, Hannah Bender, et al.
Cancers (2021) Vol. 13, Iss. 22, pp. 5838-5838
Open Access | Times Cited: 4
Page 1 - Next Page

Scroll to top